查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1764263

2025年雙磷酸鹽全球市場報告

Bisphosphonates Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年雙磷酸鹽市場規模將強勁成長。至2029年，該市場規模將成長至70.7億美元，複合年成長率為5.5%。預測期內的成長可歸因於骨骼健康研究投入的增加、對可負擔的骨質疏鬆症治療的需求成長、對老年醫療保健的日益關注、雙磷酸鹽在新興市場的使用不斷擴大，以及數字健康宣傳活動帶來的認知度不斷提高。預計這段時期的主要趨勢包括藥物傳遞系統的創新、具有更高生物有效性的先進製劑、聯合治療的開發、患者依從性技術的進步以及個人化治療方法的進步。

骨質疏鬆症盛行率的上升預計將在未來幾年推動雙磷酸鹽市場的成長。骨質疏鬆症是一種使骨骼變得脆弱並更容易骨折的疾病。骨質疏鬆症的主要原因是全球人口老化、生活習慣和缺乏適當的預防措施，因為骨骼密度會隨著老齡化的成長而降低。雙磷酸鹽可有效治療骨質疏鬆症，透過減緩骨骼分解來強化骨骼和降低骨折風險。例如，2024 年 8 月，專注於骨骼健康研究和倡導的組織「澳洲健康骨骼」報告稱，2023 年預計將有 193,482 例與骨質疏鬆症和骨質缺乏症相關的骨折，預計到 2033 年將增加 34%，達到 237,632 例。因此，骨質疏鬆症盛行率的上升是推動雙磷酸鹽市場成長的關鍵因素。

預計未來幾年，越來越多的研究和臨床試驗將推動雙磷酸鹽市場的成長。臨床試驗是對人類受試者進行的研究，旨在評估新治療方法、藥物和醫療設備的安全性、有效性和潛在副作用。這種成長很大程度上是由於對創新治療方法的需求不斷成長，以滿足不斷變化的醫療保健需求並改善患者預後。在雙磷酸鹽方面，臨床研究透過檢視治療骨質疏鬆症和骨轉移等疾病的有效性、安全性和長期效果，在推進骨骼健康治療方面發揮關鍵作用。例如，2023 年 11 月，英國製藥工業協會 (ABPI) 報告稱，英國由產業主導的臨床試驗增加了 4.3%，從 2021 年的 394 項試驗增加到 2022 年的 411 項試驗。因此，對研究和臨床試驗的更多關注對雙磷酸鹽市場擴張做出了重大貢獻。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球雙磷酸鹽：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球雙磷酸鹽市場：成長率分析
  • 全球雙磷酸鹽市場表現：規模與成長，2019-2024
  • 全球雙磷酸鹽市場預測：2024-2029 年及 2034 年規模與成長
  • 全球雙磷酸鹽：總目標市場（TAM）

第6章市場區隔

  • 全球雙磷酸鹽市場類型、績效及預測（2019-2024、2024-2029、2034）
  • 阿崙膦酸鈉
  • Ibandronate sodium
  • 利塞膦酸鹽
  • Zoledronic acid
  • 全球雙磷酸鹽市場（依給藥途徑、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 口服
  • 靜脈
  • 皮下
  • 骨內
  • 肌肉注射
  • 全球雙磷酸鹽市場（依通路、績效及預測）2019-2024、2024-2029、2034
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 其他
  • 全球雙磷酸鹽市場應用、績效及預測（2019-2024、2024-2029、2034）
  • 骨質疏鬆症
  • 柏哲氏病
  • 骨轉移
  • 其他
  • 全球雙磷酸鹽市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 居家照護
  • 醫藥零售
  • 全球雙磷酸鹽市場、阿崙膦酸鹽細分市場、按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 口服錠劑
  • 每週配方
  • 與維生素 D 結合
  • 非專利阿崙膦酸鹽
  • 全球雙磷酸鹽市場、Ibandronate sodium酸鹽細分市場、按類型、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 口服錠劑
  • 每月口服劑型
  • 靜脈注射
  • 非專利Ibandronate sodium
  • 全球雙磷酸鹽市場、利塞膦酸鹽細分市場、按類型、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 速釋片
  • 延遲釋放片
  • 每周和每月劑量
  • 與鈣結合
  • 全球雙磷酸鹽市場、Zoledronic acid細分市場、按類型、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 靜脈輸液
  • 年劑量
  • 在腫瘤學的應用
  • 用於骨質疏鬆症
  • 非專利Zoledronic acid

第7章 區域和國家分析

  • 全球雙磷酸鹽市場各地區、績效及預測（2019-2024、2024-2029、2034）
  • 全球雙磷酸鹽市場（按國家/地區分類）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 雙磷酸鹽市場：競爭格局
  • 雙磷酸鹽市場：公司簡介
    • Pfizer Inc.
    • Roche Holding AG
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Bayer AG

第31章 其他大型創新企業

  • Novartis AG
  • Eli Lilly and Company
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Organon & Co.
  • Sun Pharmaceutical Industries Ltd.
  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Ltd.
  • Alkem Laboratories
  • Natco Pharma Ltd.
  • Strides Pharma Science Limited
  • Radius Health Inc.
  • Warner Chilcott

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年雙磷酸鹽市場：提供新機會的國家
  • 2029 年雙磷酸鹽市場：細分市場帶來新機會
  • 2029 年雙磷酸鹽市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r35851

Bisphosphonates are a group of drugs that help prevent bone loss by inhibiting the activity of osteoclasts, making them a primary therapy for osteoporosis and other bone-weakening conditions. They are frequently prescribed to lower the risk of fractures in individuals with low bone density, Paget's disease, or bone metastases due to cancer. These medications aid in strengthening bones, increasing bone mineral density, and reducing fracture risk, especially in postmenopausal women and older adults.

The major types of bisphosphonates include alendronate, ibandronate, risedronate, and zoledronic acid. Alendronate is specifically used to treat and prevent bone-related disorders such as osteoporosis and Paget's disease. These drugs can be administered through various routes, including oral, intravenous, subcutaneous, intraosseous, and intramuscular. They are available through hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels. Primary applications include treating osteoporosis, Paget's disease, and bone metastases, with end users ranging from hospitals and clinics to homecare settings and pharmaceutical retailers.

The bisphosphonates market research report is one of a series of new reports from The Business Research Company that provides bisphosphonates market statistics, including bisphosphonates industry global market size, regional shares, competitors with a bisphosphonates market share, detailed bisphosphonates market segments, market trends and opportunities, and any further data you may need to thrive in the bisphosphonates industry. This bisphosphonates market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bisphosphonates market size has grown strongly in recent years. It will grow from $5.39 billion in 2024 to $5.70 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the increasing incidence of multiple myeloma, a rise in glucocorticoid-induced osteoporosis cases, the prevalence of sedentary lifestyles, greater availability of generic bisphosphonates, and the growing use of these medications in treating metastatic bone disease.

The bisphosphonates market size is expected to see strong growth in the next few years. It will grow to $7.07 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The projected growth in the forecast period can be attributed to increased investment in bone health research, rising demand for affordable osteoporosis treatments, a growing emphasis on elderly healthcare, expanding use of bisphosphonates in emerging markets, and heightened awareness driven by digital health campaigns. Key trends expected during this period include innovations in drug delivery systems, advanced formulations with enhanced bioavailability, the development of combination therapies, advancements in patient adherence technologies, and progress in personalized treatment approaches.

The rising prevalence of osteoporosis is expected to drive the growth of the bisphosphonates market in the coming years. Osteoporosis is a medical condition marked by weakened bones that are more susceptible to fractures. Its growing prevalence is mainly attributed to the aging global population, as bone density naturally declines with age, along with contributing lifestyle factors and a lack of adequate preventive measures. Bisphosphonates are effective in treating osteoporosis by slowing bone degradation, thereby strengthening bones and lowering fracture risk. For example, in August 2024, Healthy Bones Australia, an organization focused on bone health research and advocacy, reported that in 2023, there were an estimated 193,482 fractures linked to osteoporosis and osteopenia, with projections indicating a 34% increase to 237,632 fractures by 2033. Thus, the rising incidence of osteoporosis is a key factor fueling the growth of the bisphosphonates market.

The rise in research and clinical trials is expected to drive the growth of the bisphosphonates market in the coming years. Clinical trials are research studies involving human participants that assess the safety, effectiveness, and potential side effects of new treatments, drugs, or medical devices. This increase is largely fueled by the growing demand for innovative therapies to meet evolving healthcare needs and enhance patient outcomes. In the context of bisphosphonates, clinical research plays a critical role in advancing bone health treatments by examining their efficacy, safety, and long-term impact in managing conditions like osteoporosis and bone metastases. For example, in November 2023, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported a 4.3% increase in industry-initiated clinical trials in the UK, rising from 394 trials in 2021 to 411 in 2022. Thus, the growing focus on research and clinical trials is contributing significantly to the expansion of the bisphosphonates market.

In May 2023, Abiogen Pharma S.p.A., an Italy-based pharmaceutical company, acquired EffRx Pharmaceuticals SA for an undisclosed amount. This acquisition is intended to strategically enhance and diversify Abiogen's rare disease portfolio by incorporating EffRx's innovative therapies for musculoskeletal and rare conditions. It also supports Abiogen's goal of expanding its international footprint and strengthening its capabilities in the development and commercialization of specialized treatments worldwide. EffRx Pharmaceuticals SA is a Switzerland-based specialty pharmaceutical company that produces and markets bisphosphonates for the treatment of osteoporosis.

Major players in the bisphosphonates market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Organon & Co., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Natco Pharma Ltd., Strides Pharma Science Limited, Radius Health Inc., Warner Chilcott.

North America was the largest region in the bisphosphonates market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bisphosphonates report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bisphosphonates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bisphosphonates market consists of sales of oral tablets, bisphosphonate capsules, bisphosphonate injections, oral solutions, and intravenous (IV) infusions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bisphosphonates Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bisphosphonates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bisphosphonates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bisphosphonates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
  • 2) By Route Of Administration: Oral; Intravenous; Subcutaneous; Intraosseous; Intramuscular
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
  • 4) By Application: Osteoporosis; Paget's Disease; Bone Metastasis; Other Application
  • 5) By End-User: Hospitals; Clinics; Homecare Settings; Pharmaceutical Retail
  • Subsegments:
  • 1) By Alendronate: Oral Tablets; Once-Weekly Formulation; Combination With Vitamin D; Generic Alendronate
  • 2) By Ibandronate: Oral Tablets; Monthly Oral Formulation; Intravenous Injection; Generic Ibandronate
  • 3) By Risedronate: Immediate-Release Tablets; Delayed-Release Tablets; Weekly And Monthly Dosing; Combination With Calcium
  • 4) By Zoledronic Acid: Intravenous Infusion; Annual Dosing; Oncology Use; Osteoporosis Use; Generic Zoledronic Acid
  • Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bisphosphonates Market Characteristics

3. Bisphosphonates Market Trends And Strategies

4. Bisphosphonates Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bisphosphonates Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bisphosphonates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bisphosphonates Market Growth Rate Analysis
  • 5.4. Global Bisphosphonates Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bisphosphonates Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bisphosphonates Total Addressable Market (TAM)

6. Bisphosphonates Market Segmentation

  • 6.1. Global Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alendronate
  • Ibandronate
  • Risedronate
  • Zoledronic Acid
  • 6.2. Global Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Intravenous
  • Subcutaneous
  • Intraosseous
  • Intramuscular
  • 6.3. Global Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels
  • 6.4. Global Bisphosphonates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Osteoporosis
  • Paget's Disease
  • Bone Metastasis
  • Other Application
  • 6.5. Global Bisphosphonates Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare Settings
  • Pharmaceutical Retail
  • 6.6. Global Bisphosphonates Market, Sub-Segmentation Of Alendronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Tablets
  • Once-Weekly Formulation
  • Combination With Vitamin D
  • Generic Alendronate
  • 6.7. Global Bisphosphonates Market, Sub-Segmentation Of Ibandronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Tablets
  • Monthly Oral Formulation
  • Intravenous Injection
  • Generic Ibandronate
  • 6.8. Global Bisphosphonates Market, Sub-Segmentation Of Risedronate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immediate-Release Tablets
  • Delayed-Release Tablets
  • Weekly And Monthly Dosing
  • Combination With Calcium
  • 6.9. Global Bisphosphonates Market, Sub-Segmentation Of Zoledronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous Infusion
  • Annual Dosing
  • Oncology Use
  • Osteoporosis Use
  • Generic Zoledronic Acid

7. Bisphosphonates Market Regional And Country Analysis

  • 7.1. Global Bisphosphonates Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bisphosphonates Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bisphosphonates Market

  • 8.1. Asia-Pacific Bisphosphonates Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bisphosphonates Market

  • 9.1. China Bisphosphonates Market Overview
  • 9.2. China Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bisphosphonates Market

  • 10.1. India Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bisphosphonates Market

  • 11.1. Japan Bisphosphonates Market Overview
  • 11.2. Japan Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bisphosphonates Market

  • 12.1. Australia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bisphosphonates Market

  • 13.1. Indonesia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bisphosphonates Market

  • 14.1. South Korea Bisphosphonates Market Overview
  • 14.2. South Korea Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bisphosphonates Market

  • 15.1. Western Europe Bisphosphonates Market Overview
  • 15.2. Western Europe Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bisphosphonates Market

  • 16.1. UK Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bisphosphonates Market

  • 17.1. Germany Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bisphosphonates Market

  • 18.1. France Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bisphosphonates Market

  • 19.1. Italy Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bisphosphonates Market

  • 20.1. Spain Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bisphosphonates Market

  • 21.1. Eastern Europe Bisphosphonates Market Overview
  • 21.2. Eastern Europe Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bisphosphonates Market

  • 22.1. Russia Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bisphosphonates Market

  • 23.1. North America Bisphosphonates Market Overview
  • 23.2. North America Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bisphosphonates Market

  • 24.1. USA Bisphosphonates Market Overview
  • 24.2. USA Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bisphosphonates Market

  • 25.1. Canada Bisphosphonates Market Overview
  • 25.2. Canada Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bisphosphonates Market

  • 26.1. South America Bisphosphonates Market Overview
  • 26.2. South America Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bisphosphonates Market

  • 27.1. Brazil Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bisphosphonates Market

  • 28.1. Middle East Bisphosphonates Market Overview
  • 28.2. Middle East Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bisphosphonates Market

  • 29.1. Africa Bisphosphonates Market Overview
  • 29.2. Africa Bisphosphonates Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bisphosphonates Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Bisphosphonates Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bisphosphonates Market Competitive Landscape And Company Profiles

  • 30.1. Bisphosphonates Market Competitive Landscape
  • 30.2. Bisphosphonates Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Bisphosphonates Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Eli Lilly and Company
  • 31.3. Amgen Inc.
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Organon & Co.
  • 31.6. Sun Pharmaceutical Industries Ltd.
  • 31.7. Apotex Inc.
  • 31.8. Aurobindo Pharma Ltd.
  • 31.9. Dr. Reddy's Laboratories Ltd.
  • 31.10. Cipla Ltd.
  • 31.11. Alkem Laboratories
  • 31.12. Natco Pharma Ltd.
  • 31.13. Strides Pharma Science Limited
  • 31.14. Radius Health Inc.
  • 31.15. Warner Chilcott

32. Global Bisphosphonates Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bisphosphonates Market

34. Recent Developments In The Bisphosphonates Market

35. Bisphosphonates Market High Potential Countries, Segments and Strategies

  • 35.1 Bisphosphonates Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bisphosphonates Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bisphosphonates Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer